Envestnet Asset Management Inc Harmony Biosciences Holdings, Inc. Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q3 2024
A detailed history of Envestnet Asset Management Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 52,505 shares of HRMY stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,505
Previous 61,397
14.48%
Holding current value
$1.82 Million
Previous $1.85 Million
13.23%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HRMY
# of Institutions
242Shares Held
45.1MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$389 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$203 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$121 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$90.5 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$67 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.05B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...